Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-24-038213
Filing Date
2024-12-23
Accepted
2024-12-23 06:01:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 mnpr20241220_424b5.htm 424B5 278499
2 logo01.jpg GRAPHIC 7697
3 mnpr20241220_424b5img001.jpg GRAPHIC 4131
  Complete submission text file 0001437749-24-038213.txt   296047
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-268935 | Film No.: 241569622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)